%0 Journal Article
%T 139 BAY 57-9352: an inhibitor of VEGFR-2 and PDGFR receptor tyrosine kinases that demonstrates anti-angiogenic activity in vitro and in vivo
%A Elting, J.
%A Jones, R.
%A Carter, C.
%A Flynn, C.
%A Zhu, G.
%A Damico, C.
%A McHugh, M.
%A Hibner, B.
%A Kluender, H.
%A Boyer, S.
%A ,
%J European Journal of Cancer Supplements
%V 2
%N 8
%P 45
%@ 1359-6349
%D 2004-09-01
%I Elsevier BV
%~ DeepDyve